Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
95 Leser
Artikel bewerten:
(0)

3D Printing for Healthcare Applications 2016: The Technology that Could Revolutionize Pharmaceutical and Biotechnology Manufacturing - Research and Markets

DUBLIN, Jan 23, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "3D Printing for Healthcare Applications" report to their offering.

3D printing (3DP) will have a strong commercial impact across major consumer segments of the global healthcare sectors, an industry that necessitates efficient production of primarily complex or personalized products.

The opportunity to customize drugs, active pharmaceutical ingredients (APIs) and medical devices drives an era of personalized medicine. 3D printing has garnered a place on the finisher's podium as one of the highly investigated technologies for potential adoption by a plethora of key participants in the healthcare industry.

Key Topics Covered:

1.0 Executive Summary

  • Research Methodology
  • Key Findings

2.0 Overview and Definition

  • Aspects of 3D Printing versus Traditional Manufacturing
  • Crowdsourcing and 3D Printing
  • Crowdsourcers Leading the Change
  • Mass Customization and 3D Printing

3.0 3D Printing Technology Landscape

  • Major 3D Printing Technologies
  • Comparative Analysis of 3D Printing Technologies

4.0 Assessment of 3D Printing across Healthcare

  • 3D Printing has a Dynamic Impact across Multiple Verticals, which Largely Include the Healthcare and Industrial Sectors
  • 3D Printing Is a Platform for Innovation across Healthcare
  • Recent Events across the Healthcare Industry Due to 3D Printing
  • Prosthetics, Bone Grafts, and Dental Prosthetics have the Highest Innovation and Adoption rates for 3D Printing Applications
  • Prosthetics, Bone Grafts, and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications
  • Prosthetics, Bone Grafts, Ears and Vascular Tissues and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications
  • Prosthetics, Bone Grafts, Ears and Vascular Tissues and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications

5.0 Competency of 3D Printing across Healthcare

  • Business Model of Additive Manufacturing 3D Printer Manufacturers
  • Business Model of Additive Manufacturing Material Providers
  • Business Model of Additive Manufacturing Service Providers
  • Comparative Assessment of 3D Printing Technologies
  • Company Profile - Stratasys
  • Stratasys Activities in the Dental Industry - These dental 3D Printers are having a Huge Impact on the Dental Industry
  • The Use of Stratasys Printers in the Dental Industry - Case Studies Being used for Various Application in the Dental Industry
  • Stratasys Activities in the Healthcare Industry
  • The Use of Stratasys Printers in the Healthcare Industry
  • Company Profile - 3D Systems

6.0 Assessment of Potential Applications - Pharmaceutical

  • 3D Printing - Key Areas of Impact across the Pharmaceutical Sector
  • Company Profile: Aprecia Pharmaceutical
  • perational Models of Pharma Business - 3DP a Major Point of Interest for Contract Manufacturers with Pharma Clients
  • Drug Supply Chain: How is 3D Printing Interrupting the Drug Supply Chain?
  • Impact across Emerging Markets
  • Regulatory Landscape
  • Drivers and Restraints - Factors Aiding/Hindering Adoption of 3D Printing in the Pharma Industry
  • Drivers Explained
  • Restraints Explained
  • Digital Fabrication's Potential Impact on Drug Accessibility in Emerging Countries
  • Strategic Recommendations on Steps Forward

7.0 Growth Opportunities and Companies to Action

  • Growth Opportunity: 3D Printing for Healthcare
  • Major Growth Opportunities for 3DP in Healthcare
  • Strategic Imperatives for 3DP Technology Stakeholders
  • Epileptic Solutions Using 3D Printed Drugs - Aprecia Pharmaceutical, US

8.0 Patent Landscape Overview & Key Contacts

  • Patent Search Scope
  • Patent Publishing Trends, Global, 2011-2015
  • Top 20 Patent holders, Global, 2010-2015
  • Patents per Source Jurisdiction (Top 10 Patent offices), Global, 2010-2015
  • Key Company Contacts

For more information about this report visit http://www.researchandmarkets.com/research/tz4668/3d_printing_for

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

© 2017 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.